Posted by Michael Wonder on 29 Aug 2023
PHARMAC taking action to ensure supply of type 2 diabetes medicine amid worldwide shortage
29 August 2023 - PHARMAC is taking steps to ensure people with type 2 diabetes who take dulaglutide (branded as Trulicity) can continue to access the treatment while we experience further supply chain issues on top of a global shortage.
“Since March we have funded an alternative treatment called liraglutide (Victoza) which is a similar medicine to dulaglutide and there is plenty of stock available. We’re encouraging healthcare practitioners to prescribe this treatment to new patients. Liraglutide requires a different Special Authority approval from dulaglutide."
